The largest database of trusted experimental protocols

Plko 1 shrna vectors

Manufactured by Horizon Discovery

The PLKO.1 shRNA vectors are a set of plasmid vectors designed for the expression of short hairpin RNA (shRNA) in mammalian cells. These vectors utilize the RNA polymerase III U6 promoter to drive the expression of shRNA, which can be used to knockdown target gene expression through RNA interference (RNAi) mechanisms.

Automatically generated - may contain errors

2 protocols using plko 1 shrna vectors

1

Targeted shRNA Knockdown for Ciliopathy

Check if the same lab product or an alternative is used in the 5 most similar protocols
A library of shRNAs specific to the 30 human ciliopathy genes was assembled using the resources available at the UNC Gene Therapy Center. Lists of shRNA constructs and sources are provided in the Supplementary Information (Supplementary Table 4). Plasmids used for in utero electroporation were prepared using the EndoFree Plasmid kit (Qiagen). For each gene, two pools of shRNAs containing two to three individual shRNAs were randomly combined and used for electroporation. Non-silencing scrambled shRNA (sc-108080, Santa Cruz), GIPZ or pLKO.1 shRNA vectors (GE Dharmacon and UNC Gene Therapy Center) were used as control. KE of shRNAs (fold change compared with control) was measured using quantitative real-time PCR and are indicated for each shRNA group. KE of 70% was used as a threshold for shRNA pools. Each pool consisted of an equivalent amount of different shRNAs (2 or 3 per pool) listed. For BBS8, only the effective pool of ShRNA containing three different shRNAs was used. shRNAs from Santa Cruz are prepooled (four shRNAs per gene) by the vendor.
+ Open protocol
+ Expand
2

Ciliopathy Genes shRNA Library

Check if the same lab product or an alternative is used in the 5 most similar protocols
A library of shRNAs specific to the 30 human ciliopathy genes was assembled using the resources available at the UNC Gene Therapy Center. Lists of shRNA constructs and sources are provided in the supplemental information (Supp. Table 4). Plasmids used for in utero electroporation were prepared using the EndoFree Plasmid kit (Qiagen). For each gene, two pools of shRNAs containing two to three individual shRNAs were randomly combined and used for electroporation. Non-silencing scrambled shRNA (sc-108080, Santa Cruz), GIPZ or pLKO.1 shRNA vectors (GE Dharmacon and UNC Gene Therapy Center) were used as control. Knockdown efficiency (KE) of shRNAs (fold change compared to control) was measured using quantitative real time-PCR and are indicated for each shRNA group. Knockdown efficiency of 70% was used as a threshold for shRNA pools. Each pool consisted of equivalent amount of different shRNAs (2 or 3/ pool) listed. For BBS8, only the effective pool of ShRNA containing three different shRNAs was used. shRNAs from Santa Cruz are prepooled (4shRNAs/gene) by the vendor.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!